Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Infection, Response to Therapy of”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Early research (Phase 1)Study completedNCT00718172
What this trial is testing

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Not applicableStudy completedNCT00606528
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

Who this might be right for
Chronic Hepatitis C Virus Infection
University Health Network, Toronto 54
Not applicableStudy completedNCT00705224
What this trial is testing

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus
Merck Sharp & Dohme LLC 250
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)UnknownNCT01025297
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Who this might be right for
Hepatitis C
Cytheris SA 18
Not applicableLooking for participantsNCT05361603
What this trial is testing

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Who this might be right for
Hepatitis CTransmission, Intravenous Drug AbuserAddiction, Alcohol+2 more
University Hospital, Limoges 1,500
Not applicableStudy completedNCT04677153
What this trial is testing

Rapid HCV Treatment Access for Persons Who Use Drugs

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Johns Hopkins University 198
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Testing effectiveness (Phase 2)Study completedNCT01628094
What this trial is testing

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Not applicableStudy completedNCT03155113
What this trial is testing

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliero-Universitaria di Parma 77
Early research (Phase 1)Study completedNCT01473056
What this trial is testing

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Akros Pharma Inc. 29
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Post-approval studies (Phase 4)Study completedNCT00087646
What this trial is testing

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 948
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Large-scale testing (Phase 3)Study completedNCT01773070
What this trial is testing

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Who this might be right for
Hepatitis C
AbbVie (prior sponsor, Abbott) 478
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Not applicableUnknownNCT04251572
What this trial is testing

HCV Reinfection After DAA Therapy in PWID in Belgium

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofDrug Use
Hasselt University 100
Load More Results